Tag Archives: european economic area

Research – Eurosurveillance – Three simultaneous, food-borne, multi-country outbreaks of hepatitis A virus infection reported in EPIS-FWD in 2013: what does it mean for the European Union?

EURO

Between March and May 2013, three multi-country outbreaks of hepatitis A virus (HAV) infection were reported through the Epidemic Intelligence Information System for Food- and Water-borne diseases (EPIS-FWD) of the European Centre for Disease Prevention and Control (ECDC). The aim of this work is to put these outbreaks into a European Union (EU) and European Economic Area (EEA) perspective and highlight opportunities for improving detection and investigation of such outbreaks. Although HAV outbreaks are not unusual in the EU/EEA, having three large food-borne multi-country outbreaks declared within three months is an unexpected event, particularly when at least two of these outbreaks are associated with frozen berries. Factors influencing the occurrence of these events include the increased number of susceptible Europeans, the limited coverage of HAV vaccination, the global trade of potentially contaminated products introduced in the EU/EEA, and the ‘awareness chain effect’ leading to a wave of notifications. Further studies should be conducted to understand the risk posed by frozen berries. Laboratory capacity and surveillance of viral infections in the EU/EEA, as well as HAV vaccination recommendations to travellers to endemic countries should be strengthened. Finally, timely reporting food-borne events through EPIS-FWD, to ensure timely response.

 

Europe – Laboratory Preparedness for Detection and Monitoring of Shiga Toxin 2-producing Escherichia coli O104:H4 in Europe and Response to the 2011 Outbreak

Eurosurveillance

A hybrid strain of enteroaggregative and Shiga toxin 2-producing Escherichia coli (EAEC-STEC) serotype O104:H4 strain caused a large outbreak of haemolytic uraemic syndrome and bloody diarrhoea in 2011 in Europe. Two surveys were performed in the European Union (EU) and European Economic Area (EEA) countries to assess their laboratory capabilities to detect and characterise this previously uncommon STEC strain. Prior to the outbreak, 11 of the 32 countries in this survey had capacity at national reference laboratory (NRL) level for epidemic case confirmation according to the EU definition. During the outbreak, at primary diagnostic level, nine countries reported that clinical microbiology laboratories routinely used Shiga toxin detection assays suitable for diagnosis of infections with EAEC-STEC O104:H4, while 14 countries had NRL capacity to confirm epidemic cases. Six months after the outbreak, 22 countries reported NRL capacity to confirm such cases following initiatives taken by NRLs and the European Centre for Disease Prevention and Control (ECDC) Food- and Waterborne Disease and Zoonoses laboratory network. These data highlight the challenge of detection and confirmation of epidemic infections caused by atypical STEC strains and the benefits of coordinated EU laboratory networks to strengthen capabilities in response to a major outbreak.

UK/Germany/Netherlands – Increase in Cryptosporidium Notifications in 2012

ECDC

An increase in Cryptodsporidim notifications has been observed in the UK, Netherlands and Germany since August 2012 that is likely to be real and not due to surveillance or notifcations artifacts.

The available information from investigations in the United Kingdom, the Netherlands and Germany indicates that there is not a single, common source, but rather a combination of several causes. These may include climatic drivers, such as the increased rainfall in the summer of 2012 in these countries or a widely distributed commonly consumed product. There is however no evidence for it at this stage and further investigations are ongoing.

 The overall threat for the European Union/European Economic Area (EU/EEA) is considered to be low.

 EU/EEA Member States should be alert to an increase in cases as observed in the United Kingdom, the Netherlands and Germany, particularly in relation to immunocompromised and other at-risk groups as they may present with a more severe manifestation of cryptosporidiosis.